# Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

> **NCT00657059** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 151 (actual)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** irbesartan
- **DRUG:** methylprednisolone (MP) or prednisone (pred)
- **DRUG:** mycophenolate mofetil (MMF)

## Key facts

- **NCT ID:** NCT00657059
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657059, "Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00657059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*